GERM

Amplify Treatments, Testing and Advancements ETF
GERM

Overview Fund Activity
Delisted

GERM was delisted on the 5th of September, 2024.

Back to rankings

28 hedge funds and large institutions have $6.71M invested in Amplify Treatments, Testing and Advancements ETF in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 13 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
28
Holders Change
-2
Holders Change %
-6.67%
% of All Funds
0.44%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
13
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Goldman Sachs
Goldman Sachs
New York
$1.99M
2
Citadel Advisors
Citadel Advisors
Florida
$668K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
$361K
4
UBS Group
UBS Group
Switzerland
$59K
5
IA
IFP Advisors
Florida
$5K

Top Sellers

1
RJFSA
Raymond James Financial Services Advisors
Florida
$0
2
Jane Street
Jane Street
New York
$0
3
GBWM
Granite Bay Wealth Management
New Hampshire
$378K
4
Osaic Holdings
Osaic Holdings
Arizona
$58K
5
WS
Wedbush Securities
California
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
BHWM
26
Beaird Harris Wealth Management
Texas
$1K -$870 -40 -47%
Royal Bank of Canada
27
Royal Bank of Canada
Ontario, Canada
$1K – – –
RJFSA
28
Raymond James Financial Services Advisors
Florida
– -$769K -21,572 Closed
Jane Street
29
Jane Street
New York
– -$392K -10,992 Closed
WS
30
Wedbush Securities
California
– -$214K -6,011 Closed
SCA
31
Snowden Capital Advisors
New York
– -$7K -200 Closed
1
2